Question

Difficulty: Very hardInterpreting Laboratory Results

A medical resident is reviewing the laboratory results of four adult patients referred to the endocrinology clinic for evaluation of complex mineral metabolism abnormalities.

ParameterPatient 1Patient 2Patient 3Patient 4Reference Range
Calcium (mg/dL)11.111.47.69.18.4 - 10.2
Phosphorus (mg/dL)2.82.25.41.62.5 - 4.5
Intact PTH (pg/mL)55921503815 - 65
Creatinine (mg/dL)0.80.90.90.70.6 - 1.2
Urine Ca/Cr Clearance Ratio0.0050.025Not testedNot tested> 0.01
1,25-dihydroxyvitamin D (pg/mL)4558121018 - 72
25-hydroxyvitamin D (ng/mL)3832343520 - 50

Match each patient's specific laboratory profile to the most likely underlying diagnosis.

  • Patient 1 (Hypercalcemia, normal PTH, CCCR < 0.01)Familial hypocalciuric hypercalcemia
  • Patient 2 (Hypercalcemia, hypophosphatemia, elevated PTH, CCCR > 0.02)Primary hyperparathyroidism
  • Patient 3 (Hypocalcemia, hyperphosphatemia, elevated PTH, normal creatinine)Pseudohypoparathyroidism
  • Patient 4 (Normocalcemia, severe hypophosphatemia, normal PTH, low 1,25-OH-Vit D)Tumor-induced osteomalacia

Answer

The correct matches are: Patient 1 matches with Familial hypocalciuric hypercalcemia; Patient 2 matches with Primary hyperparathyroidism; Patient 3 matches with Pseudohypoparathyroidism; Patient 4 matches with Tumor-induced osteomalacia.
The correct pairings require synthesizing multiple laboratory parameters across distinct pathophysiological states. Familial hypocalciuric hypercalcemia (FHH) and primary hyperparathyroidism both present with hypercalcemia and normal/elevated PTH; however, FHH is uniquely distinguished by a urine Ca/Cr clearance ratio (CCCR) of < 0.01, whereas primary hyperparathyroidism typically has a CCCR of > 0.02. Pseudohypoparathyroidism is characterized by end-organ PTH resistance, presenting with hypocalcemia, hyperphosphatemia, and elevated PTH, but normal renal function (unlike CKD). Tumor-induced osteomalacia features ectopic FGF23 production, leading to severe hypophosphatemia, low 1,25-dihydroxyvitamin D, and normal calcium and PTH levels.

Step-by-Step Solution

1
Evaluate Patient 1 and 2, who both present with hypercalcemia and inappropriately normal or elevated PTH.
Patient 1 has a CCCR < 0.01, diagnostic of FHH. Patient 2 has a CCCR > 0.02, diagnostic of primary hyperparathyroidism.
Distinguishing between FHH and primary hyperparathyroidism relies on urinary calcium excretion analysis. FHH involves a calcium-sensing receptor defect leading to enhanced renal calcium reabsorption.
2
Analyze Patient 3's profile of hypocalcemia, hyperphosphatemia, and significantly elevated PTH.
The profile indicates target-organ resistance to PTH. The normal serum creatinine effectively rules out chronic kidney disease.
High PTH failing to correct low calcium and high phosphate suggests end-organ resistance, typical of pseudohypoparathyroidism.
3
Interpret Patient 4's isolated severe hypophosphatemia with normal calcium and normal PTH.
The concurrent low 1,25-dihydroxyvitamin D despite a normal 25-hydroxyvitamin D storage level suggests FGF23 excess.
Ectopic FGF23 causes profound renal phosphate wasting and inhibits 1-alpha-hydroxylase, perfectly matching the presentation of tumor-induced osteomalacia.

Key Concept

Accurate differential diagnosis of mineral metabolism disorders requires synthesizing multiple parameters (Calcium, Phosphorus, PTH, Vitamin D metabolites) and calculated indices (CCCR) to identify distinct patterns of hormonal resistance or ectopic secretion.

Alternative Method

For distinguishing FHH from primary hyperparathyroidism, a 24-hour urine calcium level can also be used as an initial screening tool; however, the calcium-to-creatinine clearance ratio (CCCR) is superior and more precise because it standardizes for the glomerular filtration rate.
Estimated Time:2m 30s
Rate this question